You have 9 free searches left this month | for more free features.

Condition

22q11 Deletion Syndrome (1)

Recurrent Herpes Labialis (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

phase 3 (1)

Sponsor

NanoBio Corporation (1)

Nobias Therapeutics, Inc. (1)

Collaborator

Intervention

nb-001 (2)

placebo (1)

vehicle (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

Industry (2)

Study Type

Interventional (2)

nb-001

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

22q11 Deletion Syndrome Trial in Philadelphia, Seattle, Toronto (NB-001, Placebo)

Recruiting

22q11 Deletion Syndrome

NB-001
Placebo

Aurora, Colorado
+3 more

Nov 16, 2022

Recurrent Herpes Labialis Trial in United States (NB-001, Vehicle)

Completed

Recurrent Herpes Labialis

NB-001
Vehicle

Birmingham, Alabama
+34 more

May 15, 2013